News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Melanoma Treatment
August 9, 2024
Ask The Expert About Immunotherapy Treatment for Melanoma
Charles H. Weaver, MD
September 1, 2023
Ask The Experts About ctDNA Surveillance Monitoring-Changing the Management of Melanoma
Charles H. Weaver, MD
June 21, 2021
Alrizomadlin
Charles H. Weaver, MD
April 12, 2021
What Cancers are on the Rise? How We Can Stop Them in Their Tracks
Charles H. Weaver, MD
March 28, 2021
Relatlimab Anti-LAG-3 Antibody
Charles H. Weaver, MD
October 17, 2020
Neulasta Treatment of Neutropenia Improves Treatment
Charles H. Weaver, MD
September 28, 2020
Opdivo – Yervoy Immunotherapy Prolongs Survival in Advanced Melanoma
Charles H. Weaver, MD
September 22, 2020
Treatment of Stage III Melanoma
Charles H. Weaver, MD
August 15, 2020
Treatment & Management of Melanoma Skin Cancers
Charles H. Weaver, MD
June 20, 2020
Treatment of Recurrent Melanoma
Charles H. Weaver, MD
June 10, 2020
Tumor-Infiltrating Lymphocyte Therapy for Melanoma
Charles H. Weaver, MD
May 8, 2020
Careful Follow-Up Screening Improves Outcomes for Melanoma Patients
Charles H. Weaver, MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
